Literature DB >> 15913349

Selective inhibition of factor inhibiting hypoxia-inducible factor.

Michael A McDonough1, Luke A McNeill, Melanie Tilliet, Cyril A Papamicaël, Qiu-Yun Chen, Biswadip Banerji, Kirsty S Hewitson, Christopher J Schofield.   

Abstract

A set of four non-heme iron(II) and 2-oxoglutarate-dependent enzymes catalyze the post-translational modification of a transcription factor, hypoxia inducible factor (HIF), that mediates the hypoxic response in animals. Hydroxylation of HIF both causes its degradation and limits its activity. We describe how the use of structural data coupled to solid-phase synthesis led to the discovery of a selective inhibitor of one of the HIF hydroxylases. The inhibitor N-oxalyl-d-phenylalanine was shown to inhibit the HIF asparaginyl hydroxylase (FIH) but not a HIF prolyl hydroxylase. A crystal structure of the inhibitor complexed to FIH reveals that it binds in the 2OG and, likely, in the dioxygen binding site. The results will help to enable the modulation of the hypoxic response for the up-regulation of specific genes of biomedical importance, such as erythropoietin and vascular endothelial growth factor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15913349     DOI: 10.1021/ja050841b

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  50 in total

Review 1.  The promise and failures of epigenetic therapies for cancer treatment.

Authors:  Pasano Bojang; Kenneth S Ramos
Journal:  Cancer Treat Rev       Date:  2013-07-05       Impact factor: 12.111

Review 2.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

Review 3.  Hypoxia--implications for pharmaceutical developments.

Authors:  Lucas Donovan; Scott M Welford; John Haaga; Joseph LaManna; Kingman P Strohl
Journal:  Sleep Breath       Date:  2010-07-14       Impact factor: 2.816

Review 4.  The role of histone demethylases in cancer therapy.

Authors:  Inga Hoffmann; Martin Roatsch; Martin L Schmitt; Luca Carlino; Martin Pippel; Wolfgang Sippl; Manfred Jung
Journal:  Mol Oncol       Date:  2012-08-07       Impact factor: 6.603

Review 5.  Diabetic nephropathy: a disorder of oxygen metabolism?

Authors:  Toshio Miyata; Charles van Ypersele de Strihou
Journal:  Nat Rev Nephrol       Date:  2009-12-15       Impact factor: 28.314

Review 6.  Oxygen sensing strategies in mammals and bacteria.

Authors:  Cornelius Y Taabazuing; John A Hangasky; Michael J Knapp
Journal:  J Inorg Biochem       Date:  2014-01-03       Impact factor: 4.155

Review 7.  Imposing function down a (cupin)-barrel: secondary structure and metal stereochemistry in the αKG-dependent oxygenases.

Authors:  John A Hangasky; Cornelius Y Taabazuing; Meaghan A Valliere; Michael J Knapp
Journal:  Metallomics       Date:  2013-04       Impact factor: 4.526

8.  A miniaturized screen for inhibitors of Jumonji histone demethylases.

Authors:  Masaaki Sakurai; Nathan R Rose; Lena Schultz; Amy M Quinn; Ajit Jadhav; Stanley S Ng; Udo Oppermann; Christopher J Schofield; Anton Simeonov
Journal:  Mol Biosyst       Date:  2009-10-08

Review 9.  Hypoxia. The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis.

Authors:  Barbara Muz; Moddasar N Khan; Serafim Kiriakidis; Ewa M Paleolog
Journal:  Arthritis Res Ther       Date:  2009-01-20       Impact factor: 5.156

10.  Selective inhibitors of the JMJD2 histone demethylases: combined nondenaturing mass spectrometric screening and crystallographic approaches.

Authors:  Nathan R Rose; Esther C Y Woon; Guy L Kingham; Oliver N F King; Jasmin Mecinović; Ian J Clifton; Stanley S Ng; Jobina Talib-Hardy; Udo Oppermann; Michael A McDonough; Christopher J Schofield
Journal:  J Med Chem       Date:  2010-02-25       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.